Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.

Piperacillin and vancomycin were used as initial empirical therapy for 211 febrile episodes in cancer patients. The response rate in 95 episodes of documented infection was 72%. The response of bacteremias, soft tissue infections, and pneumonias was 78, 71, and 38%, respectively. The response in inf...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Jadeja, L, Bolivar, R, Fainstein, V, Keating, M, McCredie, K, Hay, M, Bodey, G P
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1984
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176155/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6508260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.3.295
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!